# Correction: The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis

**Authors:** Lanqing Cong, Yan Deng, Shuo Cai, Gongzheng Wang, Xinya Zhao, Jingzhen He, Songbo Zhao, Li Wang

PMC · DOI: 10.1186/s13244-024-01706-8 · 2024-05-12

## Full-text entities

- **Diseases:** cirrhosis (MESH:D005355)
- **Chemicals:** gadobenate dimeglumine (MESH:C064572)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC11089016